Regulation of Cellular Functions by Cyclic Nucleotide Phosphodiesterase 8

环核苷酸磷酸二酯酶 8 对细胞功能的调节

基本信息

  • 批准号:
    7806124
  • 负责人:
  • 金额:
    $ 48.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In this supplementary research request we propose to expand the scope and accelerate the rate of progress on our project GM083926, entitled "Regulation of Cellular Functions by Cyclic Nucleotide Phosphodiesterase 8". The parent grant contains 3 specific aims, to determine the functions and mechanisms of action of PDE8s in adrenal, liver, and brown fat tissues. These are three of the tissue types in which this PDE isozyme is highly expressed. Recently, we have found that PDE8A is also highly expressed in cardiac myocytes. Moreover, our preliminary data strongly suggest that ablation of PDE8 can modulate calcium handling in isolated cardiocytes. The focus of the proposed studies will be to determine the overall cardiac phenotype of the PDE8A knockout mouse and to identify the mechanism(s) by which PDE8 regulates calcium transients in the heart. Emphasis will be placed on the roles of PDE8A in controlling cAMP dependent phosphorylation events in isolated cardiomyocytes. We will also study the effects of the gene disruption on calcium regulation in isolated cardiomyocytes and on in vivo measurements of cardiac function. The mission of the Institute of General Medicine is clearly relevant to studies on the mechanisms of control of cardiac function by modulation of calcium in the heart. The possibilities for developing an anti-arrhythmic drug based on modulation of PDE8 activity would seem quite real. PUBLIC HEALTH RELEVANCE: In this supplementary research request we propose to expand the scope and accelerate the rate of progress on our project GM083926, entitled "Regulation of Cellular Functions by Cyclic Nucleotide Phosphodiesterase 8". The focus of the proposed studies will be to determine the overall cardiac phenotype of the PDE8A knockout mouse and to identify the mechanism(s) by which PDE8 regulates calcium transients in the heart. Emphasis will be placed on the roles of PDE8A in controlling cAMP-dependent phosphorylation events in isolated cardiomyocytes. We will also study the effects of the gene disruption on in vivo measurements of cardiac function. These studies are potentially directly relevant to drug regulation of cardiac function. For example, if validated by these studies, it would appear that a drug that acted as a PDE8 activator would likely have anti-arrhythmic activity. Since most heart attacks have an arrhythmia component the relevance to public health is obvious.
描述(由申请人提供):在本补充研究申请中,我们建议扩大我们的项目GM 083926的范围并加快其进展速度,该项目名为“环核苷酸磷酸二酯酶8调节细胞功能”。母基金包含3个具体目标,以确定PDE8在肾上腺,肝脏和棕色脂肪组织中的功能和作用机制。这是PDE同工酶高度表达的三种组织类型。 最近,我们发现PDE8A也在心肌细胞中高度表达。此外,我们的初步数据强烈表明,PDE8的消融可以调节离体心肌细胞中的钙处理。拟定研究的重点是确定PDE8A敲除小鼠的总体心脏表型,并确定PDE8调节心脏钙瞬变的机制。重点将放在PDE8A在控制cAMP依赖性磷酸化事件在分离的心肌细胞中的作用。我们还将研究基因破坏对离体心肌细胞钙调节和体内心脏功能测量的影响。 普通医学研究所的使命显然与研究通过调节心脏中的钙来控制心脏功能的机制有关。开发基于PDE 8活性调节的抗疟疾药物的可能性似乎是真实的。 公共卫生相关性:在本补充研究申请中,我们建议扩大范围并加快我们的项目GM 083926的进展速度,该项目名为“环核苷酸磷酸二酯酶8对细胞功能的调节”。拟定研究的重点是确定PDE8A敲除小鼠的总体心脏表型,并确定PDE8调节心脏钙瞬变的机制。重点将放在PDE8A在控制cAMP依赖性磷酸化事件在分离的心肌细胞中的作用。我们还将研究基因破坏对体内心脏功能测量的影响。 这些研究可能与心脏功能的药物调节直接相关。例如,如果通过这些研究验证,似乎作为PDE8激活剂的药物可能具有抗肿瘤活性。由于大多数心脏病发作都有心律失常的成分,因此与公共卫生的相关性是显而易见的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph A Beavo其他文献

Cyclic nucleotide phosphodiesterases – 40 years of progress
  • DOI:
    10.1186/1471-2210-9-s1-s3
  • 发表时间:
    2009-08-11
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Joseph A Beavo;James Surapisitchat;Candance Parchen
  • 通讯作者:
    Candance Parchen
Bacterial GAF domains
  • DOI:
    10.1186/1471-2210-5-s1-s17
  • 发表时间:
    2005-06-16
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Joachim E Schultz;Sandra Bruder;Anita Schultz;Sergio E Martinez;Ning Zheng;Joseph A Beavo
  • 通讯作者:
    Joseph A Beavo
Regulation of cyclic nucleotide hydrolysis by cGMP
  • DOI:
    10.1186/1471-2210-5-s1-s9
  • 发表时间:
    2005-06-16
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Joseph A Beavo
  • 通讯作者:
    Joseph A Beavo
Specificity of commonly used cyclic nucleotides with PKA, PKG and Epac-implementing microcalorimetry to determine PDE activities
  • DOI:
    10.1186/1471-2210-7-s1-s25
  • 发表时间:
    2007-07-25
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Joseph A Beavo;Johannes L Bos;Elke Butt;Stein O Doskeland;Hans-Gottfried Genieser;Thomas R Hinds;Heiko Poppe;Holger Rehmann;Sergei D Rybalkin;Frank Schwede;Xiao-Bo Tang
  • 通讯作者:
    Xiao-Bo Tang
Molecular targets for PDE inhibitor-mediated improvement of cardiac dysfunction in the mdx mouse?
  • DOI:
    10.1186/1471-2210-11-s1-o20
  • 发表时间:
    2011-08-01
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Candace M Adamo;Dao-Fu Dai;Justin M Percival;Elina Minami;Monte S Willis;Enrico Patrucco;Sergei D Rybalkin;Stanley C Froehner;Joseph A Beavo
  • 通讯作者:
    Joseph A Beavo

Joseph A Beavo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph A Beavo', 18)}}的其他基金

Golgi-associated NO-cGMP Signaling Defect in Muscular Dystrophy
肌营养不良症中高尔基体相关的 NO-cGMP 信号缺陷
  • 批准号:
    7941082
  • 财政年份:
    2009
  • 资助金额:
    $ 48.36万
  • 项目类别:
Golgi-associated NO-cGMP Signaling Defect in Muscular Dystrophy
肌营养不良症中高尔基体相关的 NO-cGMP 信号缺陷
  • 批准号:
    8516460
  • 财政年份:
    2009
  • 资助金额:
    $ 48.36万
  • 项目类别:
Golgi-associated NO-cGMP Signaling Defect in Muscular Dystrophy
肌营养不良症中高尔基体相关的 NO-cGMP 信号缺陷
  • 批准号:
    8303029
  • 财政年份:
    2009
  • 资助金额:
    $ 48.36万
  • 项目类别:
Golgi-associated NO-cGMP Signaling Defect in Muscular Dystrophy
肌营养不良症中高尔基体相关的 NO-cGMP 信号缺陷
  • 批准号:
    7781662
  • 财政年份:
    2009
  • 资助金额:
    $ 48.36万
  • 项目类别:
Golgi-associated NO-cGMP Signaling Defect in Muscular Dystrophy
肌营养不良症中高尔基体相关的 NO-cGMP 信号缺陷
  • 批准号:
    8118226
  • 财政年份:
    2009
  • 资助金额:
    $ 48.36万
  • 项目类别:
Regulation of Cellular Functions by Cyclic Nucleotide Phosphodiesterase 8
环核苷酸磷酸二酯酶 8 对细胞功能的调节
  • 批准号:
    8072053
  • 财政年份:
    2008
  • 资助金额:
    $ 48.36万
  • 项目类别:
Regulation of Cellular Functions by Cyclic Nucleotide Phosphodiesterase 8
环核苷酸磷酸二酯酶 8 对细胞功能的调节
  • 批准号:
    7525488
  • 财政年份:
    2008
  • 资助金额:
    $ 48.36万
  • 项目类别:
Phosphodiesterase 8 Synergies: Regulation of Brown Fat, and Cardiac Functions
磷酸二酯酶 8 协同作用:棕色脂肪和心脏功能的调节
  • 批准号:
    8510658
  • 财政年份:
    2008
  • 资助金额:
    $ 48.36万
  • 项目类别:
Phosphodiesterase 8 Synergies: Regulation of Brown Fat, and Cardiac Functions
磷酸二酯酶 8 协同作用:棕色脂肪和心脏功能的调节
  • 批准号:
    8676811
  • 财政年份:
    2008
  • 资助金额:
    $ 48.36万
  • 项目类别:
Phosphodiesterase 8 Synergies: Regulation of Brown Fat, and Cardiac Functions
磷酸二酯酶 8 协同作用:棕色脂肪和心脏功能的调节
  • 批准号:
    8914758
  • 财政年份:
    2008
  • 资助金额:
    $ 48.36万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 48.36万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了